This press release contains " forward-looking statements " within the meaning of the Private Securities Litigation Reform Act of 1995 relating to preclinical and clinical development of Amicus ' candidate drug products , the timing and reporting of results from preclinical studies and clinical trial evaluating Amicus ' candidate drug products , and the projected cash position for the Company .